• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿透性或狭窄性疾病是克罗恩病首次和重复切除手术时间的主要决定因素。

Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.

机构信息

Healthcare Evaluation Unit, Institute of Social and Preventive Medicine, Lausanne, Switzerland.

出版信息

Digestion. 2013;87(3):212-21. doi: 10.1159/000350954. Epub 2013 May 23.

DOI:10.1159/000350954
PMID:23711401
Abstract

BACKGROUND

About 80% of patients with Crohn's disease (CD) require bowel resection and up to 65% will undergo a second resection within 10 years. This study reports clinical risk factors for resection surgery (RS) and repeat RS.

METHODS

Retrospective cohort study, using data from patients included in the Swiss Inflammatory Bowel Disease Cohort. Cox regression analyses were performed to estimate rates of initial and repeated RS.

RESULTS

Out of 1,138 CD cohort patients, 417 (36.6%) had already undergone RS at the time of inclusion. Kaplan-Meier curves showed that the probability of being free of RS was 65% after 10 years, 42% after 20 years, and 23% after 40 years. Perianal involvement (PA) did not modify this probability to a significant extent. The main adjusted risk factors for RS were smoking at diagnosis (hazard ratio (HR) = 1.33; p = 0.006), stricturing with vs. without PA (HR = 4.91 vs. 4.11; p < 0.001) or penetrating disease with vs. without PA (HR = 3.53 vs. 4.58; p < 0.001). The risk factor for repeat RS was penetrating disease with vs. without PA (HR = 3.17 vs. 2.24; p < 0.05).

CONCLUSION

The risk of RS was confirmed to be very high for CD in our cohort. Smoking status at diagnosis, but mostly penetrating and stricturing diseases increase the risk of RS.

摘要

背景

约 80%的克罗恩病(CD)患者需要进行肠道切除术,多达 65%的患者在 10 年内将进行第二次切除术。本研究报告了与肠道切除术(RS)和重复 RS 相关的临床危险因素。

方法

回顾性队列研究,使用纳入瑞士炎症性肠病队列研究中的患者数据。采用 Cox 回归分析来评估首次和重复 RS 的发生率。

结果

在 1138 名 CD 队列患者中,417 名(36.6%)在纳入时已经接受过 RS。Kaplan-Meier 曲线显示,10 年后 RS 无进展的概率为 65%,20 年后为 42%,40 年后为 23%。肛周病变(PA)并未显著改变这一概率。RS 的主要调整后危险因素是诊断时吸烟(风险比(HR)=1.33;p=0.006)、伴或不伴 PA 的狭窄性疾病(HR=4.91 比 4.11;p<0.001)或伴或不伴 PA 的穿透性疾病(HR=3.53 比 4.58;p<0.001)。重复 RS 的危险因素是伴或不伴 PA 的穿透性疾病(HR=3.17 比 2.24;p<0.05)。

结论

在我们的队列中,CD 患者的 RS 风险被证实非常高。诊断时的吸烟状况,但主要是穿透性和狭窄性疾病,增加了 RS 的风险。

相似文献

1
Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.穿透性或狭窄性疾病是克罗恩病首次和重复切除手术时间的主要决定因素。
Digestion. 2013;87(3):212-21. doi: 10.1159/000350954. Epub 2013 May 23.
2
Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.免疫调节剂与非穿透性非狭窄性克罗恩病患者首次手术风险较低相关。
Am J Gastroenterol. 2009 Nov;104(11):2754-9. doi: 10.1038/ajg.2009.387. Epub 2009 Jul 7.
3
Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.205 例克罗恩病患者行初次手术的临床特征和危险因素:一项华南队列分析。
Dis Colon Rectum. 2011 Sep;54(9):1147-54. doi: 10.1097/DCR.0b013e318222ddc3.
4
Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.儿童期起病的克罗恩病肠道手术发生率及相关危险因素
Inflamm Bowel Dis. 2016 Dec;22(12):2917-2923. doi: 10.1097/MIB.0000000000000937.
5
Repeat intestinal resections increase the risk of recurrence of Crohn's disease.重复肠道切除术会增加克罗恩病复发的风险。
Dis Colon Rectum. 2013 Jul;56(7):881-7. doi: 10.1097/DCR.0b013e31828cb80c.
6
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.因急腹症接受手术时首次诊断出的克罗恩病的临床病程。
Dig Liver Dis. 2009 Apr;41(4):269-76. doi: 10.1016/j.dld.2008.09.010. Epub 2008 Oct 26.
7
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.早期使用免疫调节剂或肿瘤坏死因子拮抗剂对克罗恩病肠道损伤及手术的影响
Aliment Pharmacol Ther. 2015 Oct;42(8):977-89. doi: 10.1111/apt.13363. Epub 2015 Aug 14.
8
[Risk factors for initial bowel resection and postoperative recurrence in patients with Crohn disease].[克罗恩病患者初次肠道切除及术后复发的危险因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Mar;14(3):176-80.
9
Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.早期使用硫唑嘌呤/生物制剂治疗与克罗恩病患者(无论是否吸烟)首次手术风险降低和手术时间延迟有关,但不增加再次手术风险,而吸烟则降低溃疡性结肠炎患者结肠切除术的风险。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):872-9. doi: 10.1097/MEG.0b013e32833036d9.
10
Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification.吸烟是否会影响克罗恩病的表型?基于蒙特利尔分类法的分析。
Am J Gastroenterol. 2007 Mar;102(3):577-88. doi: 10.1111/j.1572-0241.2007.01064.x.

引用本文的文献

1
The Pathogenesis of Inflammatory Bowel Diseases.炎症性肠病的发病机制
Surg Clin North Am. 2025 Apr;105(2):201-215. doi: 10.1016/j.suc.2024.10.008. Epub 2024 Nov 26.
2
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis.炎症性肠病临床试验中入选标准的演变:一项临床试验数据库分析
United European Gastroenterol J. 2025 May;13(4):542-551. doi: 10.1002/ueg2.12731. Epub 2024 Dec 19.
3
Inflammatory Bowel Disease: Immune Function, Tissue Fibrosis and Current Therapies.
炎症性肠病:免疫功能、组织纤维化和当前治疗方法。
Int J Mol Sci. 2024 Jun 11;25(12):6416. doi: 10.3390/ijms25126416.
4
Duodenal Crohn's disease: Case report and systematic review.十二指肠克罗恩病:病例报告与系统综述
World J Methodol. 2024 Mar 20;14(1):88619. doi: 10.5662/wjm.v14.i1.88619.
5
Fecal microbiota related to postoperative endoscopic recurrence in patients with Crohn's disease.与克罗恩病患者术后内镜复发相关的粪便微生物群
Gastroenterol Rep (Oxf). 2024 Mar 23;12:goae017. doi: 10.1093/gastro/goae017. eCollection 2024.
6
Fibrosis in IBD: from pathogenesis to therapeutic targets.炎症性肠病中的纤维化:从发病机制到治疗靶点。
Gut. 2024 Apr 5;73(5):854-866. doi: 10.1136/gutjnl-2023-329963.
7
Xanthohumol Interferes with the Activation of TGF-β Signaling in the Process Leading to Intestinal Fibrosis.黄腐酚可干扰 TGF-β 信号通路的激活,从而阻止肠道纤维化的发生。
Nutrients. 2022 Dec 25;15(1):99. doi: 10.3390/nu15010099.
8
Management of Crohn's stricture: medical, endoscopic and surgical therapies.克罗恩病狭窄的管理:药物、内镜及手术治疗
Frontline Gastroenterol. 2022 Feb 16;13(6):524-530. doi: 10.1136/flgastro-2021-101827. eCollection 2022.
9
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy.炎症性肠病中的肠纤维化和间充质干细胞治疗的前景。
Front Immunol. 2022 Mar 18;13:835005. doi: 10.3389/fimmu.2022.835005. eCollection 2022.
10
Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease.肠道微生物群对克罗恩病肠道纤维化的作用
Front Med (Lausanne). 2022 Feb 7;9:826240. doi: 10.3389/fmed.2022.826240. eCollection 2022.